161 related articles for article (PubMed ID: 8673629)
1. [From cholesterol to oxysterols. Current data].
Luu B
C R Seances Soc Biol Fil; 1995; 189(5):827-37. PubMed ID: 8673629
[TBL] [Abstract][Full Text] [Related]
2. Relevance and mechanism of oxysterol stereospecifity in coronary artery disease.
Rimner A; Al Makdessi S; Sweidan H; Wischhusen J; Rabenstein B; Shatat K; Mayer P; Spyridopoulos I
Free Radic Biol Med; 2005 Feb; 38(4):535-44. PubMed ID: 15649656
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
4. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised.
Gill S; Chow R; Brown AJ
Prog Lipid Res; 2008 Nov; 47(6):391-404. PubMed ID: 18502209
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols.
Lemaire-Ewing S; Prunet C; Montange T; Vejux A; Berthier A; Bessède G; Corcos L; Gambert P; Néel D; Lizard G
Cell Biol Toxicol; 2005 Mar; 21(2):97-114. PubMed ID: 16142584
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of oxygenated sterols: physiological and pathological implications.
Hwang PL
Bioessays; 1991 Nov; 13(11):583-9. PubMed ID: 1772414
[TBL] [Abstract][Full Text] [Related]
7. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
8. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases.
Lordan S; Mackrill JJ; O'Brien NM
J Nutr Biochem; 2009 May; 20(5):321-36. PubMed ID: 19345313
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic effect of oxidized products of cholesterol.
Hubbard RW; Ono Y; Sanchez A
Prog Food Nutr Sci; 1989; 13(1):17-44. PubMed ID: 2678267
[TBL] [Abstract][Full Text] [Related]
10. Membrane and protein interactions of oxysterols.
Massey JB
Curr Opin Lipidol; 2006 Jun; 17(3):296-301. PubMed ID: 16680036
[TBL] [Abstract][Full Text] [Related]
11. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
12. Oxysterols: A world to explore.
Otaegui-Arrazola A; Menéndez-Carreño M; Ansorena D; Astiasarán I
Food Chem Toxicol; 2010 Dec; 48(12):3289-303. PubMed ID: 20870006
[TBL] [Abstract][Full Text] [Related]
13. Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis.
Brown AJ; Jessup W
Mol Aspects Med; 2009 Jun; 30(3):111-22. PubMed ID: 19248801
[TBL] [Abstract][Full Text] [Related]
14. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
15. Oxysterols: novel biologic roles for the 21st century.
Javitt NB
Steroids; 2008 Feb; 73(2):149-57. PubMed ID: 18068744
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of oxysterols. Effect of two water-soluble monophosphoric acid diesters of 7 beta-hydroxycholesterol on mastocytoma P815 in vivo.
Christ M; Ji YH; Moog C; Pannecoucke X; Schmitt G; Bischoff P; Luu B
Anticancer Res; 1991; 11(1):359-64. PubMed ID: 1902075
[TBL] [Abstract][Full Text] [Related]
17. Noncholesterol sterols.
Vecka M; Zak A; Tvrzická E
Acta Univ Carol Med Monogr; 2008; 154():5-101. PubMed ID: 19283968
[TBL] [Abstract][Full Text] [Related]
18. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase.
Singh DK; Li L; Porter TD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1020-6. PubMed ID: 16714400
[TBL] [Abstract][Full Text] [Related]
19. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
